HomeOrderingContact UsAbout UsInvestor InformationSite Map

Optimase® Polymerase

Description Ordering Warranty
 
 
For high-fidelity PCR in mutation detection, SNP discovery, and high-fidelity cloning

Optimase Polymerase is a thermostable DNA polymerase with an efficient 3' to 5' proof-reading exonuclease activity developed for unprecedented PCR performance in single nucleotide polymorphism (SNP) and mutation discovery studies. Initially developed for denaturing high performance liquid chromatography (DHPLC) research1-4, Optimase Polymerase is the enzyme of choice for other applications requiring high fidelity PCR amplification.

View FAQs about Optimase Polymerase

Applications
  • SNP and mutation discovery and scoring with various techniques such as SURVEYOR® Nuclease genome scanning, DHPLC, SSCP, DGGE and others
  • High fidelity cloning
Features   Benefits
High fidelity proofreading polymerase. It has a 3’-5’ exonuclease activity.   Offers superior PCR fidelity over other proofreading polymerases1-3. View product information sheet. View application note.
Enhanced Optimase Polymerase Buffer System   Enhances the life of the DNASep® Cartridge in DHPLC experiments; does not interfere with other downstream applications, and increases amplification robustness and fidelity
Free online support and access to the automated Optimase ProtocolWriter™ for PCR protocol design and Optimase MasterMix Calculator™ found at www.MutationDiscovery.com™   Enables simple and automated generation of PCR protocols; thus minimizing PCR optimization

References
  1. Muhr, D., Wagner, T. and Oefner, P. 2002. Polymerase chain reaction fidelity and denaturing high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci, 782:105-110. Abstract Library Entry
  2. Nickerson, M. 2003. “Influence of PCR on DHPLC Polymorphism Characterization.” In Hecker, K. (Editor): Genetic Variance Detection: The Nuts&Bolts of DHPLC in Genomics.. 2003, DNA Press.
  3. Application Note #119u. 2002. Transgenomic Optimase Polymerase delivers highest fidelity in PCR for WAVE® System analysis. http://www.transgenomic.com
  4. Jagmohan-Changur, S., et al. 2003. EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer. Cancer Res, 63:154-158. Abstract Library Entry
  5. Mo, J.Y., Maki, H., and Sekiguchi, M. 1991. Mutation specificity of the dnaE173 mutator associated with a defect in the catalytic subunit of DNA polymerase III of Escherichia coli. J. Mol. Biol. 222: 925-936.
Contact WebmasterSend Page To ColleaguePrintable PageChange Country United States
Copyright © 1997-2008 Transgenomic, Inc., All Rights Reserved.the power of discovery™